Secukinumab for the Treatment of Psoriatic Arthritis: Comparative Effectiveness Versus Adalimumab Using a Matching-Adjusted Indirect Comparison

被引：0
作者：
Nash, Peter [1 ]
McInnes, Iain B. [2 ]
Mease, Philip J. [3 ,4 ]
Choy, Ernest H. [5 ,6 ]
Thom, Howard [7 ]
Kalyvas, Chrysostomos [8 ]
Gandhi, Kunal [9 ]
Mpofu, Shephard [10 ]
Jugl, Steffen [10 ]
机构：
[1] Univ Queensland, Dept Med, Brisbane, Qld, Australia
[2] Univ Glasgow, Glasgow, Lanark, Scotland
[3] Swedish Med Ctr, Seattle, WA USA
[4] Univ Washington, Seattle, WA 98195 USA
[5] Cardiff Univ, Sch Med, Rheumatol Sect, Cardiff, S Glam, Wales
[6] Cardiff Univ, CREATE Ctr, Div Infect & Immun, Cardiff, S Glam, Wales
[7] Univ Bristol, Bristol, Avon, England
[8] MAPI Grp, Houten, Netherlands
[9] Novartis Pharmaceut, E Hanover, NJ USA
[10] Novartis Pharma AG, Basel, Switzerland
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1738
引用
收藏
页数：2
相关论文
共 50 条
[41]   Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis [J].
Maksymowych, Walter P. ;
Thom, Howard ;
Morup, Michael F. ;
Taieb, Vanessa ;
Willems, Damon ;
Lyris, Nikos ;
Gaffney, Karl .
RHEUMATOLOGY AND THERAPY, 2024, 11 (04) :1023-1041
[42]   A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF BIMEKIZUMAB AND SECUKINUMAB AT 52 WEEKS FOR THE TREATMENT OF RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS [J].
Maksymowych, W. P. ;
Thom, H. ;
Morup, M. ;
Taieb, V ;
Willems, D. ;
Gaffney, K. .
VALUE IN HEALTH, 2023, 26 (12) :S30-S30
[43]   A COST PER RESPONDER ANALYSIS OF SECUKINUMAB VS. ADALIMUMAB BASED ON A MATCHING-ADJUSTED INDIRECT COMPARISON OF EFFICACY DATA FOR THE TREATMETN OF PSORIATIC ARTHRITIS AT 48 WEEKS FROM THE IRISH PAYER PERSPECTIVE [J].
Gunda, P. ;
Nikoglou, E. ;
Jugl, S. M. ;
Murphy, A. .
VALUE IN HEALTH, 2017, 20 (09) :A532-A532
[44]   Matching-adjusted indirect treatment comparison of ozanimod versus teriflunomide for relapsing multiple sclerosis [J].
Cohan, Stanley ;
Tencer, Tom ;
Arndorfer, Stella ;
Zhu, Xuelian ;
Zivkovic, Marko ;
Kumar, Jinender .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
[45]   Matching-Adjusted Indirect Comparison of Osilodrostat Versus Metyrapone for the Treatment of Cushing's Syndrome [J].
Hickey, Conor ;
Gueron, Beatrice ;
Schmidt, Fabian ;
Tyas, Emma ;
Binowski, Grzegorz ;
Pivonello, Rosario .
ADVANCES IN THERAPY, 2025, 42 (07) :3472-3485
[46]   Matching-adjusted indirect comparison for treatment of NTRK fusion cancer with larotrectinib versus entrectinib [J].
Garcia-Foncillas, J. ;
Bokemeyer, C. ;
Italiano, A. ;
Keating, K. ;
Paracha, N. ;
Fellous, M. ;
Marian, M. ;
Fillbrunn, M. ;
Gao, W. ;
Ayyagari, R. ;
Lassen, U. N. .
ANNALS OF ONCOLOGY, 2021, 32 :S401-S401
[47]   Comparative Effectiveness Without Head-to-Head Trials A Method for Matching-Adjusted Indirect Comparisons Applied to Psoriasis Treatment with Adalimumab or Etanercept [J].
Signorovitch, James E. ;
Wu, Eric Q. ;
Yu, Andrew P. ;
Gerrits, Charles M. ;
Kantor, Evan ;
Bao, Yanjun ;
Gupta, Shiraz R. ;
Mulani, Parvez M. .
PHARMACOECONOMICS, 2010, 28 (10) :935-945
[48]   COMPARATIVE EFFECTIVENESS IN PAIN AND HAQ-DI IMPROVEMENT FOR BARICITINIB VERSUS ADALIMUMAB, TOCILIZUMAB, AND TOFACITINIB MONOTHERAPIES IN CSDMARD-NAIVE RHEUMATOID ARTHRITIS PATIENTS: A MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) [J].
Fautrel, R. ;
Zhu, B. ;
Taylor, P. C. ;
van de Laar, M. ;
Emery, P. ;
De Leonardis, F. ;
Gaich, C. ;
Nicolay, C. ;
Kadziola, Z. ;
De La Torre, I. ;
Fleischmann, R. .
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 :973-974
[49]   Comparative Effectiveness in Pain and HAQ-DI Improvement for Baricitinib Versus Adalimumab, Tocilizumab, and Tofacitinib Monotherapies in Csdmard-Naive Rheumatoid Arthritis Patients: A Matching-Adjusted Indirect Comparison (MAIC) [J].
Fautrel, Bruno ;
Zhu, Baojin ;
Taylor, Peter C. ;
van de Laar, Mart ;
Emery, Paul ;
de Leonardis, Francesco ;
Gaich, Carol L. ;
Nicolay, Claudia ;
Kadziola, Zbigniew ;
de la Torre, Inmaculada ;
Fleischmann, Roy .
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[50]   A COST PER RESPONDER ANALYSIS OF SECUKINUMAB VS ADALIMUMAB BASED ON A MATCHING-ADJUSTED INDIRECT COMPARISON FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS FROM A GERMAN PAYER PERSPECTIVE [J].
Gunda, P. ;
Kandhare, A. ;
Nikoglou, E. ;
Jugl, S. M. ;
Kneidl, J. ;
Neidhardt, K. .
VALUE IN HEALTH, 2016, 19 (07) :A537-A537
12345